Bacilligen
HOME
ABOUT BACILLIGEN
Board of Advisors
Founders
TECHNOLOGIES
rMB - Recombinant Mycobacteria/Bladder Cancer
BVS - Bacilligen Vector System/Vaccines
PARTNERING
NEWS
CONTACT US

 
Bacilligen, Inc.

An Early-Stage Biotechnology Company Developing Solutions for Cancer, Infectious Disease, and Rapid Response Biological Manufacturing

BACILLIGEN NEWS

6/17/2008 | Bacilligen, Inc. to Present at BIO 2008 International Convention
Bacilligen, Inc. announced today it is presenting at the BIO 2008 International Convention taking place June 17-20th in San Diego, California. Read More...

1/30/2008 | Bacilligen, Inc. Files Patent Applications On BVS Recombinant Capsid Vector Technology and rMB Improved Bladder Cancer Therapy
Bacilligen, Inc. announced today that it has filed patent applications covering two of its platform technologies. Read More...

6/20/2007 | Bacilligen, Inc. Receives Investment From Maryland Department of Business and Economic Development Challenge Investment Program.
Bacilligen announces they have accepted a $50,000 investment from the State's Challenge Investment Program fund. Read More...

Home      Contact Us